title: Human alpha-defensins block papillomavirus infection.
abstract: Sexually transmitted human papillomaviruses (HPVs) are the primary cause of cervical cancer. Recent advances in techniques for production of papillomaviral vectors [known as pseudoviruses (PsVs)] have made it possible to perform high-throughput screens for compounds that might block the initial stages of papillomavirus infection. We have used PsVs to screen a variety of compounds that might function as inhibitors of HPV infection, with emphasis on human peptides previously implicated in innate antimicrobial immunity. Little is known about the possible activity of these peptides against nonenveloped viruses, such as HPVs. Our screen revealed that human alpha-defensins 1-3 [known as human neutrophil peptides (HNPs) 1-3] and human alpha-defensin 5 (HD-5) are potent antagonists of infection by both cutaneous and mucosal papillomavirus types. In contrast, human beta-defensins 1 and 2 displayed little or no anti-HPV activity. HD-5 was particularly active against sexually transmitted HPV types, with 50% inhibitory doses in the high ng/ml range. Microscopic studies of PsV inhibition by the alpha-defensins revealed that they block virion escape from endocytic vesicles but not virion binding or internalization. Consistent with this finding, PsVs remained susceptible to inhibition by alpha-defensins for many hours after initial binding to cells. HNPs 1-3 and HD-5 have been reported to be present in the female genital tract at levels that overlap those that inhibit HPVs in vitro, suggesting that they could present a natural barrier to the sexual transmission of HPV and could serve as the basis of a broad-spectrum topical microbicide.
authors.affiliation: Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, MD 20892-4263, USA.
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Buck
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Day
authors.forename: Cynthia D
authors.initials: CD
authors.lastname: Thompson
authors.forename: Jacek
authors.initials: J
authors.lastname: Lubkowski
authors.forename: Wuyuan
authors.initials: W
authors.lastname: Lu
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Lowy
authors.forename: John T
authors.initials: JT
authors.lastname: Schiller
mesh_terms: D000890:Anti-Infective Agents / Q000737:chemistry; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry; D002460:Cell Line; D045744:Cell Line, Tumor; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D020128:Inhibitory Concentration 50; D008856:Microscopy, Fluorescence; D008969:Molecular Sequence Data; D009154:Mutation; D027383:Papillomaviridae / Q000235:genetics; D030361:Papillomavirus Infections; D011485:Protein Binding; D015398:Signal Transduction; D013997:Time Factors; D023084:alpha-Defensins / Q000378:metabolism / Q000502:physiology*; D054804:Cathelicidins
chemical_list: D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D023084:alpha-Defensins; D049452:Green Fluorescent Proteins; D054804:Cathelicidins